MA45902A

Acetate salt of buprenorphine and methods for preparing buprenorphine

Abstract

This record has no abstract on file.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Published
  4. Today

40 members in 19 offices

This recordMember, by publication datePriority claim9 more offices are in the list below

Priority claims4

Priority claims
DocumentOfficeKindDate
201562131114United States of AmericaP
201562131114United States of AmericaP
201562131114P
US201562131114P

Members40

Family members, oldest first
DocumentOfficeKind
CA2977732A1CanadaA1
CA3104099A1CanadaA1
WO2016142877A1World Intellectual Property Organization (WIPO)A1
TW201639856ATaiwan Province of ChinaA
AR103902A1ArgentinaA1
US2017197975A1United States of AmericaA1
AU2016230750A1AustraliaA1
MX2017011606AMexicoA
SG11201707350TASingaporeA
CO2017009130A2ColombiaA2
IL254384A0IsraelA0
IL254384D0IsraelD0
KR20170137738ARepublic of KoreaA
EA201792014A1Eurasian Patent Organization (EAPO)A1
CN107660207AChinaA
PH12017501641A1PhilippinesA1
EP3283490A1European Patent Office (EPO)A1
JP2018507882AJapanA
US9926329B2United States of AmericaB2
BR112017019357A2BrazilA2
US2018162866A1United States of AmericaA1
US2018235955A1United States of AmericaA1
NZ735736ANew ZealandA
US10278967B2United States of AmericaB2
AU2016230750B2AustraliaB2
AU2019203308A1AustraliaA1
MA45902AThis recordMoroccoA
US10406152B2United States of AmericaB2
US2019298713A1United States of AmericaA1
US2019314364A1United States of AmericaA1
JP2020033359AJapanA
JP6660399B2JapanB2
KR20200045010ARepublic of KoreaA
TWI699367BTaiwan Province of ChinaB
CN107660207BChinaB
TW202037597ATaiwan Province of ChinaA
US10835528B2United States of AmericaB2
US10874662B2United States of AmericaB2
US2021046066A1United States of AmericaA1
CA2977732CCanadaC